Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News GSK and EFSD announce diabetes research funding

GSK and EFSD announce diabetes research funding

20th November 2007

GlaxoSmithKline (GSK) and the European Foundation for the Study of Diabetes (EFSD) have announced a total of one million euros (0.715 million pounds) for diabetes research in Europe for 2007 and 2008.

Half the funding will be allocated this year, with the remainder awarded next year, with award winners each receiving 0.1 million euros for their research projects.

Winners for 2007 include Professor Christophe Magnan in Paris, Dr Lorella Mareslli of Pisa, Dr Claudia Miele of Naples, Dr Giovambattista Pani of Rome and Professor Michael Roden of Vienna, who will spend the grants on a range of studies in the field of diabetes.

Philippe Halban, chairman of the EFSD, said: “This programme shows the academic community the strength and value of partnerships between EFSD, a non-profit funding agency, and a major pharmaceutical company like GSK.”

He added that increased funding for research on metabolic toxicity is vital to enhance understanding of type two diabetes and will potentially improve treatment options for the condition.

In September 2007, Pfizer announced a joint awards initiative with the EFDS to provide research grants to projects investigating the reduction of cardiovascular risks in patients with diabetes, with applications open from January to March next year.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.